SCHEMBL68235

SCHEMBL68235

CN(Cc1cc(Br)cs1)C(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1G O43497 1/20 0.39
CACNA1B Q00975 1/20 0.39
CACNA1C Q13936 1/20 0.39
AAK1 Q2M2I8 2/20 0.37
HTR2C P28335 2/20 0.37
SLC6A4 P31645 2/20 0.37
HSP90AA1 P07900 1/20 0.36
HSP90AB1 P08238 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
PDK1 Q15118 1/20 0.36
PDK2 Q15119 1/20 0.36
PDK3 Q15120 1/20 0.36
PDK4 Q16654 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
GLS O94925 1/20 0.35
RIPK1 Q13546 3/20 0.35
SOS1 Q07889 1/20 0.34
FPR3 P25089 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4404774 0.86 AAK1 (0.36) CACNA1GCACNA1BCACNA1CAAK1SLC6A4
SCHEMBL25033758 0.84 CACNA1G (0.40) CACNA1GCACNA1BCACNA1CHTR2CSLC6A4
SCHEMBL25363849 0.80 CACNA1G (0.36) CACNA1GCACNA1BCACNA1CHTR2CSLC6A4
SCHEMBL25364299 0.80 HTR2C (0.35) CACNA1GCACNA1BCACNA1CAAK1HTR2C
SCHEMBL29524123 0.79 AAK1 (0.34) AAK1HSP90AA1HSP90AB1CYP2C9CYP2C19
SCHEMBL25366478 0.79 PRSS1 (0.36) CACNA1GCACNA1BCACNA1CAAK1HTR2C
SCHEMBL2843431 0.79 HTR2C (0.43) HTR2CSLC6A4GLSRIPK1GBA1
SCHEMBL22771190 0.78 RIPK1 (0.43) CACNA1GCACNA1BCACNA1CAAK1HTR2C
SCHEMBL30466777 0.78 AR (0.44) CACNA1GCACNA1BCACNA1CHTR2CSLC6A4
SCHEMBL1400848 0.77 LMNA (0.42) SLC6A4HSP90AA1HSP90AB1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8022079-B2 Methods of modulating PPAR gamma-type receptors GALDERMA RESEARCH & DEVELOPMENT (FR) 2011-09-20 US disclosed
EP-1638964-B1 NOVEL COMPOUNDS THAT MODULATE PPAR-GAMMA TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS GALDERMA RES & DEV (FR) 2011-07-27 EP disclosed
EP-1814871-B1 COMPOUNDS THAT MODULATE PPARY TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS GALDERMA RES & DEV (FR) 2011-03-02 EP disclosed
EP-2190822-A2 5-MEMBERED HETEROCYCLIC COMPOUNDS AS PROTON PUMP INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2010-06-02 EP disclosed
WO-2009041705-A9 5-MEMBERED HETEROCYCLIC COMPOUNDS AS PROTON PUMP INHIBITORS TAKEDA PHARMACEUTICAL (JP) 2009-08-13 WO disclosed
WO-2009041705-A2 5-MEMBERED HETEROCYCLIC COMPOUNDS AS PROTON PUMP INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-04-02 WO disclosed